Revenue

9 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

Revenue

Revenue

The following table presents the Company’s disaggregated revenue by offering type (in thousands):

	Three Months Ended September 30,
	2024				2023
	Total Net Revenues		Percentage of Total Net Revenues		Total Net Revenues		Percentage of Total Net Revenues
Patient Services revenue recognized at a point in time:
Direct products	$	685	1.9	%	$	570	1.8	%
Third-Party Payer products	3,917		11.1	%	3,425		10.7	%
Patient Services revenue recognized over time:
Direct rental services	1,923		5.4	%	1,840		5.8	%
Third-Party Payer rental services	12,277		34.8	%	11,003		34.5	%
Total Patient Services accounted for under ASC 606	18,802		53.2	%	16,838		52.8	%
Device Solutions revenue recognized at a point in time:
Products	4,731		13.4	%	3,593		11.3	%
Services	2,575		7.3	%	2,573		8.1	%
Device Solutions revenue recognized over time:
Services	1,841		5.2	%	1,807		5.7	%
Total Device Solutions accounted for under ASC 606	9,147		25.9	%	7,973		25.0	%
Total Revenue Accounted for under ASC 606	27,949		79.1	%	24,811		77.8	%
Patient Services lease revenue	1,978		5.6	%	2,451		7.7	%
Device Solutions lease revenue	5,393		15.3	%	4,647		14.6	%
Total Revenue accounted for under ASC 842, Leases	7,371		20.9	%	7,098		22.2	%
Total Net Revenue	$	35,320	100.0	%	$	31,909	100.0	%

	Nine Months Ended September 30,
	2024				2023
	Total Net Revenues		Percentage of Total Net Revenues		Total Net Revenues		Percentage of Total Net Revenues
Patient Services revenue recognized at a point in time:
Direct products	$	2,030	2.0	%	$	1,727	1.8	%
Third-Party Payer products	11,182		11.1	%	10,198		10.8	%
Patient Services revenue recognized over time:
Direct rental services	5,724		5.7	%	5,574		5.9	%
Third-Party Payer rental services	35,144		34.8	%	32,913		35.0	%
Total Patient Services accounted for under ASC 606	54,080		53.5	%	50,412		53.6	%
Device Solutions revenue recognized at a point in time:
Products	12,886		12.8	%	11,199		11.9	%
Services	7,442		7.4	%	7,608		8.1	%
Device Solutions revenue recognized over time:
Services	5,850		5.8	%	4,079		4.3	%
Total Device Solutions accounted for under ASC 606	26,178		25.9	%	22,886		24.3	%
Total Revenue Accounted for under ASC 606	80,258		79.5	%	73,298		78.0	%
Patient Services Lease Revenue	5,537		5.5	%	6,970		7.4	%
Device Solutions Lease Revenue	15,218		15.1	%	13,746		14.6	%
Total Revenue accounted for under ASC 842, Leases	20,755		20.5	%	20,716		22.0	%
Total Net Revenue	$	101,013	100.0	%	$	94,014	100.0	%

Contract Balances

(dollars in thousands)	As of September 30, 2024		As of December 31, 2023		$ Change
Accounts receivable, net	$	22,761	$	19,830	$	2,931
Contract assets	$	980	$	1,271	$	(291)

The change in contract assets during the nine months ended September 30, 2024 included $8.2 million of revenue recognized for which the payment is subject to conditions other than the passage of time, which was fully offset by $8.5 million of contract assets reclassified to accounts receivable as our right to consideration for these contract assets became unconditional. Contract assets are included in other current assets on the Company's condensed consolidated balance sheets.